Table 3.
Treatment group | Dose mg/kg | TP (mg/dL) | MDA (nmol/g) | NP-SH (mg/dL) |
---|---|---|---|---|
Normal | 95.84 ± 6.27 | 0.96 ± 0.11 | 8.16 ± 0.42 | |
CCl4 | 1.25 mL/kg | 30.78 ± 3.13∗∗∗a | 8.55 ± 1.07∗∗∗a | 4.25 ± 0.42∗∗∗a |
AM + CCl4 | 250 | 36.21 ± 3.22b | 5.57 ± 0.77∗b | 6.20 ± 0.56∗b |
AM + CCl4 | 500 | 56.63 ± 3.80∗∗∗b | 2.257 ± 0.20∗∗∗b | 6.28 ± 0.48∗b |
Silymarin + CCl4 | 10 | 56.64 ± 7.61∗∗∗b | 2.87 ± 0.64∗∗∗b | 7.36 ± 0.54∗∗b |
All values represent mean ± SEM. * P < 0.05; ** P < 0.01; *** P < 0.001; ANOVA, followed by Dunnett's multiple comparison test. aAs compared with normal group. bAs compared with CCl4 only group.